| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 11 | 2022 | 1466 | 1.040 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 2 | 2018 | 46 | 0.790 |
Why?
|
| DNA Methylation | 14 | 2022 | 2669 | 0.700 |
Why?
|
| Sequence Alignment | 4 | 2012 | 844 | 0.650 |
Why?
|
| Sequence Analysis, DNA | 11 | 2022 | 2483 | 0.620 |
Why?
|
| p300-CBP Transcription Factors | 4 | 2020 | 110 | 0.600 |
Why?
|
| Protein-Arginine N-Methyltransferases | 5 | 2023 | 209 | 0.580 |
Why?
|
| Transcription Factors | 9 | 2023 | 5270 | 0.550 |
Why?
|
| Dioxygenases | 4 | 2022 | 159 | 0.510 |
Why?
|
| Cell Nucleus | 2 | 2018 | 1620 | 0.500 |
Why?
|
| Nuclear Proteins | 8 | 2021 | 3343 | 0.480 |
Why?
|
| Epigenesis, Genetic | 9 | 2022 | 1399 | 0.420 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 2 | 2022 | 33 | 0.420 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 3 | 2022 | 426 | 0.420 |
Why?
|
| DNA-Binding Proteins | 7 | 2022 | 4821 | 0.420 |
Why?
|
| Repressor Proteins | 5 | 2019 | 1664 | 0.400 |
Why?
|
| Genomic Imprinting | 3 | 2012 | 194 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2020 | 810 | 0.370 |
Why?
|
| Transcriptome | 7 | 2022 | 1859 | 0.360 |
Why?
|
| Mice | 37 | 2023 | 34495 | 0.350 |
Why?
|
| Algorithms | 4 | 2012 | 3890 | 0.340 |
Why?
|
| Sequence Analysis, RNA | 5 | 2019 | 651 | 0.340 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2019 | 425 | 0.330 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 1471 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 4 | 2017 | 1443 | 0.310 |
Why?
|
| Homeodomain Proteins | 3 | 2022 | 1143 | 0.310 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2007 | 38 | 0.300 |
Why?
|
| Prostate | 3 | 2017 | 1088 | 0.300 |
Why?
|
| Meiosis | 3 | 2017 | 166 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2019 | 2359 | 0.290 |
Why?
|
| Animals | 40 | 2023 | 59536 | 0.280 |
Why?
|
| Liver Cirrhosis, Biliary | 4 | 2010 | 78 | 0.280 |
Why?
|
| Histone Demethylases | 2 | 2019 | 144 | 0.280 |
Why?
|
| Base Sequence | 5 | 2012 | 4917 | 0.270 |
Why?
|
| Chromosome Segregation | 1 | 2005 | 82 | 0.270 |
Why?
|
| Carrier Proteins | 4 | 2021 | 2022 | 0.270 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2005 | 110 | 0.260 |
Why?
|
| Gene Expression Profiling | 12 | 2022 | 5159 | 0.260 |
Why?
|
| Cell Differentiation | 8 | 2019 | 4078 | 0.260 |
Why?
|
| Genome | 6 | 2022 | 672 | 0.250 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 2291 | 0.240 |
Why?
|
| SOXC Transcription Factors | 2 | 2014 | 53 | 0.240 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 575 | 0.240 |
Why?
|
| Chromatin | 6 | 2023 | 942 | 0.230 |
Why?
|
| Gene Library | 2 | 2022 | 294 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 7 | 2019 | 3101 | 0.230 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 4233 | 0.230 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2019 | 310 | 0.230 |
Why?
|
| DNA | 4 | 2023 | 2693 | 0.220 |
Why?
|
| Cigarette Smoking | 1 | 2023 | 88 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 8873 | 0.210 |
Why?
|
| Cerebellar Diseases | 1 | 2023 | 89 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2012 | 410 | 0.210 |
Why?
|
| Cell Cycle Proteins | 2 | 2022 | 2045 | 0.210 |
Why?
|
| Mutation, Missense | 2 | 2019 | 1152 | 0.210 |
Why?
|
| Aurora Kinase A | 1 | 2022 | 202 | 0.200 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2021 | 494 | 0.200 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2021 | 31 | 0.200 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2022 | 113 | 0.200 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 5767 | 0.190 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2020 | 63 | 0.190 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2020 | 25 | 0.190 |
Why?
|
| Endopeptidases | 2 | 2019 | 220 | 0.190 |
Why?
|
| DNA, Neoplasm | 2 | 2016 | 1910 | 0.180 |
Why?
|
| CREB-Binding Protein | 1 | 2020 | 86 | 0.180 |
Why?
|
| Carcinosarcoma | 1 | 2021 | 146 | 0.180 |
Why?
|
| Receptors, Odorant | 1 | 2020 | 47 | 0.180 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 92 | 0.180 |
Why?
|
| DNA Helicases | 1 | 2022 | 434 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 264 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 422 | 0.180 |
Why?
|
| HEK293 Cells | 7 | 2019 | 1489 | 0.180 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 621 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 534 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 362 | 0.170 |
Why?
|
| Stem Cells | 2 | 2016 | 1213 | 0.170 |
Why?
|
| Embryonic Development | 2 | 2019 | 306 | 0.170 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2015 | 1094 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2012 | 4549 | 0.170 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2021 | 221 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2018 | 35 | 0.170 |
Why?
|
| Zinc Fingers | 1 | 2019 | 205 | 0.170 |
Why?
|
| Osteolysis | 1 | 2019 | 80 | 0.170 |
Why?
|
| Flagella | 1 | 2018 | 39 | 0.170 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 73 | 0.160 |
Why?
|
| Sequence Analysis, Protein | 2 | 2008 | 81 | 0.160 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2018 | 31 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 483 | 0.160 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 411 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2022 | 2488 | 0.160 |
Why?
|
| Embryoid Bodies | 1 | 2017 | 12 | 0.160 |
Why?
|
| LIM Domain Proteins | 1 | 2018 | 104 | 0.160 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 94 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 5178 | 0.160 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2023 | 406 | 0.160 |
Why?
|
| Nucleosomes | 2 | 2023 | 143 | 0.160 |
Why?
|
| Mice, Knockout | 9 | 2018 | 5710 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2023 | 6915 | 0.160 |
Why?
|
| Humans | 53 | 2023 | 261506 | 0.150 |
Why?
|
| Carcinogenesis | 2 | 2021 | 1026 | 0.150 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2017 | 51 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2022 | 461 | 0.150 |
Why?
|
| Models, Genetic | 3 | 2012 | 1113 | 0.150 |
Why?
|
| Face | 1 | 2019 | 273 | 0.150 |
Why?
|
| Leukemia | 2 | 2018 | 1635 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 270 | 0.150 |
Why?
|
| CpG Islands | 5 | 2022 | 633 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 1070 | 0.140 |
Why?
|
| Oocytes | 2 | 2016 | 414 | 0.140 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2016 | 36 | 0.140 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2016 | 38 | 0.140 |
Why?
|
| Homologous Recombination | 1 | 2017 | 185 | 0.140 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 257 | 0.140 |
Why?
|
| Protein Binding | 7 | 2019 | 3438 | 0.140 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 4143 | 0.140 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2017 | 182 | 0.140 |
Why?
|
| Spermatogenesis | 1 | 2018 | 308 | 0.140 |
Why?
|
| Mutation | 9 | 2023 | 15179 | 0.140 |
Why?
|
| Blastocyst | 1 | 2016 | 124 | 0.140 |
Why?
|
| Genome, Human | 6 | 2015 | 1869 | 0.130 |
Why?
|
| Cytoplasm | 1 | 2018 | 652 | 0.130 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2022 | 2979 | 0.130 |
Why?
|
| cdc25 Phosphatases | 1 | 2015 | 97 | 0.130 |
Why?
|
| Infertility, Male | 1 | 2018 | 297 | 0.130 |
Why?
|
| Oncogenes | 1 | 2018 | 673 | 0.130 |
Why?
|
| Cell Line, Tumor | 10 | 2022 | 14551 | 0.130 |
Why?
|
| Genotype | 6 | 2020 | 4109 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 4053 | 0.130 |
Why?
|
| Epilepsy | 1 | 2023 | 883 | 0.130 |
Why?
|
| MicroRNAs | 3 | 2017 | 2947 | 0.130 |
Why?
|
| Placenta | 1 | 2019 | 516 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2018 | 2084 | 0.130 |
Why?
|
| DNA Damage | 3 | 2017 | 1954 | 0.130 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2014 | 31 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 101 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2014 | 23 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 703 | 0.120 |
Why?
|
| Interferon-beta | 1 | 2014 | 102 | 0.120 |
Why?
|
| Genes, rel | 2 | 2014 | 8 | 0.120 |
Why?
|
| Genes | 2 | 2012 | 491 | 0.120 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2014 | 57 | 0.120 |
Why?
|
| Proteins | 2 | 2014 | 1963 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2019 | 6150 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2021 | 1058 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2020 | 1869 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 4757 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 895 | 0.120 |
Why?
|
| Acetylation | 3 | 2022 | 508 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2021 | 2450 | 0.120 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2015 | 167 | 0.120 |
Why?
|
| Exosomes | 1 | 2016 | 253 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 598 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 848 | 0.120 |
Why?
|
| Methylation | 4 | 2018 | 597 | 0.120 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 15694 | 0.110 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 2265 | 0.110 |
Why?
|
| Twist-Related Protein 1 | 1 | 2013 | 127 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 1294 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2016 | 1987 | 0.110 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2012 | 27 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 467 | 0.110 |
Why?
|
| Yeasts | 1 | 2012 | 74 | 0.110 |
Why?
|
| Alleles | 4 | 2012 | 2437 | 0.110 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 7222 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 184 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 1498 | 0.110 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 122 | 0.110 |
Why?
|
| Software | 3 | 2012 | 1321 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1129 | 0.110 |
Why?
|
| Liver | 1 | 2022 | 2961 | 0.100 |
Why?
|
| Cell Lineage | 3 | 2023 | 668 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 6942 | 0.100 |
Why?
|
| Female | 23 | 2022 | 141928 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 1215 | 0.100 |
Why?
|
| Arginine | 2 | 2014 | 500 | 0.100 |
Why?
|
| Male | 21 | 2022 | 123000 | 0.100 |
Why?
|
| Markov Chains | 2 | 2008 | 175 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2015 | 2796 | 0.100 |
Why?
|
| Phenotype | 6 | 2023 | 6295 | 0.100 |
Why?
|
| Guanylate Cyclase | 1 | 2010 | 74 | 0.100 |
Why?
|
| Signal Transduction | 6 | 2019 | 11965 | 0.090 |
Why?
|
| Cytokinesis | 1 | 2010 | 57 | 0.090 |
Why?
|
| Cell Line | 4 | 2020 | 5114 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2018 | 2358 | 0.090 |
Why?
|
| Transcription, Genetic | 6 | 2014 | 3154 | 0.090 |
Why?
|
| Binding Sites | 4 | 2019 | 2171 | 0.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 674 | 0.090 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2015 | 560 | 0.090 |
Why?
|
| Leukocytes | 1 | 2012 | 422 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2018 | 1242 | 0.090 |
Why?
|
| Cellular Reprogramming | 1 | 2012 | 189 | 0.090 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2010 | 113 | 0.090 |
Why?
|
| Interleukin-12 Receptor beta 2 Subunit | 1 | 2009 | 2 | 0.090 |
Why?
|
| Escherichia coli | 2 | 2019 | 1203 | 0.090 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2009 | 8 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1664 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 2009 | 67 | 0.090 |
Why?
|
| HLA-DQ Antigens | 1 | 2009 | 58 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 11538 | 0.090 |
Why?
|
| Gene Expression | 4 | 2019 | 3570 | 0.090 |
Why?
|
| Cell Movement | 1 | 2017 | 2466 | 0.080 |
Why?
|
| Genetic Linkage | 2 | 2007 | 512 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2020 | 5637 | 0.080 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 558 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 1390 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2008 | 100 | 0.080 |
Why?
|
| Disease Progression | 3 | 2021 | 6682 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 492 | 0.080 |
Why?
|
| Genes, Neoplasm | 3 | 2015 | 324 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 973 | 0.080 |
Why?
|
| Escherichia coli Proteins | 1 | 2010 | 359 | 0.080 |
Why?
|
| Antigens, CD | 2 | 2012 | 1385 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 2819 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3230 | 0.070 |
Why?
|
| Penetrance | 1 | 2007 | 126 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2020 | 3341 | 0.070 |
Why?
|
| RNA Interference | 3 | 2016 | 1408 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2007 | 233 | 0.070 |
Why?
|
| Castration | 2 | 2016 | 122 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2019 | 216 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2012 | 518 | 0.070 |
Why?
|
| Spermatozoa | 2 | 2018 | 315 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 905 | 0.070 |
Why?
|
| NIH 3T3 Cells | 2 | 2019 | 260 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 374 | 0.070 |
Why?
|
| RNA | 2 | 2012 | 1013 | 0.070 |
Why?
|
| Canada | 3 | 2012 | 429 | 0.070 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2007 | 192 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1077 | 0.070 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 430 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2005 | 234 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2007 | 1529 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2021 | 9180 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 1029 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2018 | 6100 | 0.060 |
Why?
|
| Apoptosis | 1 | 2018 | 7591 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 5061 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2012 | 2295 | 0.060 |
Why?
|
| Testis | 2 | 2018 | 717 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 3981 | 0.060 |
Why?
|
| Hematopoiesis | 2 | 2018 | 560 | 0.060 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2015 | 69 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2016 | 7226 | 0.060 |
Why?
|
| Pedigree | 1 | 2007 | 1890 | 0.060 |
Why?
|
| WW Domain-Containing Oxidoreductase | 1 | 2023 | 50 | 0.060 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 74 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 2508 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2027 | 0.050 |
Why?
|
| Piperazines | 1 | 2011 | 2101 | 0.050 |
Why?
|
| Cell Survival | 2 | 2019 | 3045 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2018 | 943 | 0.050 |
Why?
|
| Breast | 2 | 2021 | 1344 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 803 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2022 | 132 | 0.050 |
Why?
|
| Genomics | 2 | 2012 | 2738 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 571 | 0.050 |
Why?
|
| Protein Transport | 2 | 2014 | 734 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 208 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 1053 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2020 | 23 | 0.050 |
Why?
|
| Smad1 Protein | 1 | 2020 | 35 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2019 | 1732 | 0.050 |
Why?
|
| Protein Multimerization | 2 | 2012 | 240 | 0.050 |
Why?
|
| Follistatin | 1 | 2020 | 55 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 57 | 0.050 |
Why?
|
| Parents | 1 | 2007 | 998 | 0.050 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2020 | 22 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 361 | 0.050 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2019 | 18 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2864 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2021 | 223 | 0.050 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2019 | 21 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2021 | 233 | 0.040 |
Why?
|
| Nucleotide Motifs | 1 | 2019 | 62 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 338 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 2527 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 131 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2021 | 557 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 483 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 318 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2017 | 1682 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2019 | 105 | 0.040 |
Why?
|
| Anions | 1 | 2018 | 39 | 0.040 |
Why?
|
| Ear, Inner | 1 | 2019 | 57 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2019 | 47 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 370 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2011 | 3518 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 131 | 0.040 |
Why?
|
| Haplotypes | 2 | 2012 | 856 | 0.040 |
Why?
|
| Ion Transport | 1 | 2018 | 79 | 0.040 |
Why?
|
| Spermatids | 1 | 2018 | 42 | 0.040 |
Why?
|
| CTLA-4 Antigen | 2 | 2015 | 657 | 0.040 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 801 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 6009 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 280 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 339 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 419 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2016 | 5395 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2017 | 1450 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 644 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2018 | 106 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 470 | 0.040 |
Why?
|
| Bayes Theorem | 2 | 2012 | 1021 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2016 | 1818 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2021 | 533 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2018 | 165 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 4654 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2018 | 229 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 292 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2019 | 1213 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2019 | 145 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2019 | 481 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 842 | 0.040 |
Why?
|
| China | 1 | 2018 | 606 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2018 | 271 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2017 | 86 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 301 | 0.040 |
Why?
|
| Retroelements | 1 | 2016 | 47 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 334 | 0.040 |
Why?
|
| Thiolester Hydrolases | 1 | 2016 | 34 | 0.030 |
Why?
|
| Azacitidine | 1 | 2022 | 1149 | 0.030 |
Why?
|
| Hormones | 1 | 2017 | 266 | 0.030 |
Why?
|
| Liquid Biopsy | 1 | 2016 | 158 | 0.030 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2016 | 73 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 154 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2022 | 992 | 0.030 |
Why?
|
| Culture Media | 1 | 2016 | 319 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2016 | 83 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 249 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 5047 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2017 | 177 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 694 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 1442 | 0.030 |
Why?
|
| Steroids | 1 | 2017 | 356 | 0.030 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 245 | 0.030 |
Why?
|
| Fertility | 1 | 2018 | 336 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 1033 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2015 | 176 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 147 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2018 | 619 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2014 | 74 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 170 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 1823 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2074 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 171 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 550 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2014 | 302 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2014 | 64 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2014 | 147 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 338 | 0.030 |
Why?
|
| Adult | 6 | 2021 | 77950 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 15193 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2014 | 56 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2019 | 1694 | 0.030 |
Why?
|
| Organoids | 1 | 2016 | 287 | 0.030 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2014 | 27 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 392 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1516 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 2927 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 279 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 733 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 12926 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 237 | 0.030 |
Why?
|
| Cytosine | 1 | 2014 | 141 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 575 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 1183 | 0.030 |
Why?
|
| Biomarkers, Tumor | 3 | 2018 | 10331 | 0.030 |
Why?
|
| Nuclear Export Signals | 1 | 2012 | 10 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 750 | 0.030 |
Why?
|
| E-Box Elements | 1 | 2012 | 12 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1130 | 0.030 |
Why?
|
| Nuclear Localization Signals | 1 | 2012 | 46 | 0.030 |
Why?
|
| TATA Box | 1 | 2012 | 36 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 303 | 0.030 |
Why?
|
| Insulator Elements | 1 | 2012 | 7 | 0.030 |
Why?
|
| Androgens | 1 | 2016 | 511 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2012 | 13 | 0.030 |
Why?
|
| Middle Aged | 6 | 2021 | 86204 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2012 | 68 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 51 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3821 | 0.030 |
Why?
|
| Genome, Fungal | 1 | 2012 | 54 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 1048 | 0.030 |
Why?
|
| Allelic Imbalance | 1 | 2012 | 41 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 771 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 5539 | 0.030 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2012 | 97 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2012 | 108 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 217 | 0.030 |
Why?
|
| Alu Elements | 1 | 2012 | 88 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2012 | 206 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 878 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 1742 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 325 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2012 | 234 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 362 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 192 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1681 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2012 | 469 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3719 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 673 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 2944 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2014 | 519 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 2010 | 62 | 0.020 |
Why?
|
| Scattering, Small Angle | 1 | 2010 | 62 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 1099 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2010 | 168 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 76 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 992 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 677 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 1282 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2216 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Lung | 1 | 2021 | 3151 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2009 | 29 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 1163 | 0.020 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2009 | 34 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 70117 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 837 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2010 | 276 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 1872 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 3251 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 660 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 627 | 0.020 |
Why?
|
| Wound Healing | 1 | 2014 | 815 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2009 | 76 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2009 | 264 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 13658 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 157 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 4758 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 501 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 460 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 1258 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 2489 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2011 | 1665 | 0.020 |
Why?
|
| Adolescent | 3 | 2015 | 31252 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 6089 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2009 | 546 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2576 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 1171 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 5112 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 295 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 1439 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7573 | 0.020 |
Why?
|
| Benzamides | 1 | 2011 | 1832 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 3441 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 2316 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 4307 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 671 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 21445 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2330 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 4298 | 0.010 |
Why?
|
| Family | 1 | 2007 | 736 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 17523 | 0.010 |
Why?
|
| Glioma | 1 | 2012 | 1963 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 29902 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 2086 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 14289 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 21713 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 7789 | 0.010 |
Why?
|
| United States | 1 | 2012 | 15433 | 0.010 |
Why?
|
| Child | 1 | 2015 | 29154 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 32848 | 0.010 |
Why?
|